Milbank LLP Litigation & Arbitration partner and head of the firm’s Intellectual Property Litigation and Licensing Group David Gindler will speak at Life Sciences Patent Network (LSPN) North America Fall 2022 conference on November 1, 2022.
Mr. Gindler’s presentation will be entitled “US Patent Landscape – Retrospective and Outlook” at 8:40 a.m. PDT. Topics to be covered in his session will include:
- Recent changes to induced infringement law and “skinny labels” at SCOTUS
- Patent eligibility developments and potential impact of new legislation
- Status of certiorari petitions related to disclosure requirements for composition of matter and method of treatment claims, and impact of possible outcomes
- Latest PTAB reforms creating a fairer and more predictable venue for patent challenges
- Efforts to boost collaboration between the USPTO and FDA Comment end
David Gindler focuses on IP disputes, with an emphasis on complex patent litigation. Recognized nationally by Chambers for his expertise in life sciences matters, Mr. Gindler’s work spans a broad array of industries and technologies, including pharmaceuticals, biologics, diagnostic tests, and medical devices. He has achieved extraordinary trial outcomes for both plaintiffs and defendants, including obtaining a $302 million verdict for breach of a research and license agreement, as well as defeating a $217 million damages claim where liability had already been established in an earlier trial.
The LSPN conference explores some of the biggest challenges facing the Life Sciences Patent Community right now and offers insights from leading experts on how to overcome them. To learn more and register, click here.
